SANGAMO THERAPEUTICS INC
SGMO
SGMO was delisted on the 4th of May, 2026.
6 hedge funds and large institutions have $29K invested in SANGAMO THERAPEUTICS INC in 2026 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 107 closing their positions.
24% less call options, than puts
Call options by funds: $25K | Put options by funds: $33K
31.19% less ownership
Funds ownership: 31.32% → 0.13% (-31%)
95% less funds holding
Funds holding: 113 → 6 (-107)
98% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 107
100% less capital inflows, than outflows
Capital inflows: $20.3K | Capital outflows: $25.9M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Simplex Trading
Chicago,
Illinois
|
+$17.9K |
| 2 |
Heritage Investment Group
Pompano Beach,
Florida
|
+$2.34K |
| 3 |
Flow Traders U.S.
New York
|
+$8 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Armistice Capital
New York
|
-$10M |
| 2 |
Vanguard Capital Management
Malvern,
Pennsylvania
|
-$3.14M |
| 3 |
Two Sigma Investments
New York
|
-$1.55M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$1.31M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$1.13M |
SGMO Hedge Fund Activity: Q2 2026 in Review
6 of the 8,377 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q2 2026, worth a combined $29K — down 100% from $26M a quarter earlier.
Sellers outnumbered buyers: 107 funds closed out of SGMO and 2 opened new positions — a net loss of 105 holders — while 0 trimmed existing stakes and 1 added.
The largest buyer was Simplex Trading, opening a new position worth an estimated $17.9K. The largest seller was Armistice Capital, exiting entirely with an estimated $10M sold.
- 6 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q2 2026, down from 113 in Q1 2026.
- Funds reported $29K of SANGAMO THERAPEUTICS INC stock for Q2 2026, down 100% quarter-over-quarter.
- 2 funds opened new SANGAMO THERAPEUTICS INC positions in Q2 2026 and 107 closed out, a net change of -105 holders.
- The largest SANGAMO THERAPEUTICS INC buyer in Q2 2026 was Simplex Trading, an estimated $17.9K added.
- The largest SANGAMO THERAPEUTICS INC seller in Q2 2026 was Armistice Capital, an estimated $10M sold.
Based on aggregated 13F filings for Q2 2026.